Harbor Medtech
Irvine, US · Founded 2010 · Delaware corporation · 1 known investors
Harbor MedTech is a commercial-stage regenerative medicine company developing collagen matrix products based on its patented BriDGE technology for orthopedic soft tissue repair, surgical repair (hernia and breast reconstruction), and chronic skin wound healing. Its products are aimed at clinical and surgical use and include two FDA-cleared and CE-marked devices.
Founders & leadership
WJ
W. Jerome MezgerExecutive
WJ
William Jerome MezgerExecutive
Board
JC
Jay ChamplainBoard director
JJ
James J. JungwirthBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6M disclosed across 3 rounds · 2012–2017
▶$250KraisedOct 2017 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedOct 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William Jerome MezgerExecutive Officer, Director
- Jay ChamplainDirector
- Peter ReineckeDirector
- Offering amount
- $8M
- Amount sold
- $250K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedNov 2016 · 4 investors · Other Health CareRule 506(b)
▶$5.1MraisedNov 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jay ChamplainDirector
- W. Jerome MezgerExecutive Officer, Director
- Offering amount
- $8.5M
- Amount sold
- $5.1M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$669.7KraisedFeb 2012 · 10 investors · Other Health CareRule 506(b)
▶$669.7KraisedFeb 2012 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James J. JungwirthDirector
- Jay ChamplainDirector
- William Jerome MezgerExecutive Officer, Director
- Offering amount
- $1.7M
- Amount sold
- $669.7K
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Globus Medical4 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Organogenesis3 shared keywordsOrganogenesis is a regenerative medicine company that develops and commercializes products for the advanced wound care and surgical biologics markets, supplying clinicians and their patients. Its product portfolio includes tissue-based therapies such as Apligraf for wound care.
Read the Press Release3 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Companies competing with Harbor Medtech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Harbor Medtech do?
- Harbor MedTech is a commercial-stage regenerative medicine company developing collagen matrix products based on its patented BriDGE technology for orthopedic soft tissue repair, surgical repair (hernia and breast reconstruction), and chronic skin wound healing. Its products are aimed at clinical and surgical use and include two FDA-cleared and CE-marked devices.
- Who are Harbor Medtech's investors?
- Harbor Medtech's investors include Bascom Ventures.
- How much funding has Harbor Medtech raised?
- Harbor Medtech has disclosed $6M raised across 3 rounds.
- Where is Harbor Medtech headquartered?
- Harbor Medtech is headquartered in Irvine, US.